Mani Inc
TSE:7730

Watchlist Manager
Mani Inc Logo
Mani Inc
TSE:7730
Watchlist
Price: 1 697 JPY -1.68%
Market Cap: ¥167.2B

P/OCF

16.2
Current
29%
Cheaper
vs 3-y average of 22.6

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
16.2
=
Market Cap
¥183.7B
/
Operating Cash Flow
¥10.3B

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
16.2
=
Market Cap
¥183.7B
/
Operating Cash Flow
¥10.3B

Valuation Scenarios

Mani Inc is trading below its 3-year average

If P/OCF returns to its 3-Year Average (22.6), the stock would be worth ¥2 373.74 (40% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-29%
Maximum Upside
+48%
Average Upside
13%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 16.2 ¥1 697
0%
3-Year Average 22.6 ¥2 373.74
+40%
5-Year Average 24 ¥2 514.6
+48%
Industry Average 15.3 ¥1 608.21
-5%
Country Average 11.5 ¥1 201.49
-29%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
JP
Mani Inc
TSE:7730
167.2B JPY 16.2 22.3
JP
Hoya Corp
TSE:7741
9.9T JPY 39.4 39.6
US
Medline Inc
NASDAQ:MDLN
58.1B USD 0 0
CH
Alcon AG
SIX:ALC
29B CHF 15.7 36.4
DK
Coloplast A/S
CSE:COLO B
92B DKK 13.2 22.8
US
Align Technology Inc
NASDAQ:ALGN
12.7B USD 21.3 30.8
UK
ConvaTec Group PLC
LSE:CTEC
4.2B GBP 11.8 31.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
39.1B CNY 26.7 23.7
JP
Asahi Intecc Co Ltd
TSE:7747
905.8B JPY 22.4 51.2
KR
HLB Inc
KOSDAQ:028300
8.3T KRW -90 -37.8
CA
Bausch + Lomb Corp
NYSE:BLCO
5.6B USD 19.6 -15.4
P/E Multiple
Earnings Growth PEG
JP
Mani Inc
TSE:7730
Average P/E: 32.3
22.3
22%
1
JP
Hoya Corp
TSE:7741
39.6
15%
2.6
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
CH
Alcon AG
SIX:ALC
36.4
32%
1.1
DK
Coloplast A/S
CSE:COLO B
22.8
21%
1.1
US
Align Technology Inc
NASDAQ:ALGN
30.8
34%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
31.8
41%
0.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.7
9%
2.6
JP
A
Asahi Intecc Co Ltd
TSE:7747
51.2
40%
1.3
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -37.8 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.4 N/A N/A

Market Distribution

Higher than 70% of companies in Japan
Percentile
70th
Based on 4 634 companies
70th percentile
16.2
Low
0.1 — 8
Typical Range
8 — 16
High
16 —
Distribution Statistics
Japan
Min 0.1
30th Percentile 8
Median 11.5
70th Percentile 16
Max 277 515 329.3

Mani Inc
Glance View

Market Cap
167.2B JPY
Industry
Health Care

In the dynamic landscape of modern manufacturing, Mani Inc. emerges as a pivotal player, weaving together innovation and tradition in the realm of precision tools. Founded in the late 20th century, the company quickly distinguished itself by specializing in the design and production of high-quality dental and medical instruments. At its core, Mani Inc. thrives on its commitment to quality and reliability, underpinning its operations with cutting-edge technology and meticulous craftsmanship. Boasting a global presence, the company navigates a complex supply chain and adheres to stringent regulatory standards, ensuring its tools meet the diverse needs of practitioners around the world. Mani Inc. engages directly with dental professionals and healthcare institutions, building lasting relationships that are strengthened by the consistent performance and longevity of its products. Economically, Mani Inc. capitalizes on its expansive distribution network and brand loyalty to generate revenue, with a business model that focuses on both direct sales and partnerships with distributors. This approach allows the company not only to reach a wide array of international markets but also to tailor its offerings to specific regional demands. Its commitment to research and development propels innovation that further solidifies its market position, helping to safeguard against the fluctuations that often characterize the medical tools segment. By investing significantly in R&D, Mani Inc. ensures its product lineup remains at the forefront of technology and efficiency, thereby reinforcing its competitive edge in an industry where precision is paramount.

Intrinsic Value
1 476.99 JPY
Overvaluation 13%
Intrinsic Value
Price ¥1 697
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett